GEN’s Editor-in-Chief John Sterling interviews William Caldwell, CEO of Advanced Cell Technology.

Previous articleResearchers Unable to Verify 85 Gene Variations Associated with ACS
Next articleArray BioPharma Earns Milestone from AstraZeneca